NGF and Alzheimer disease: On a similar note, we show that intranasal treatment with NGF in a mouse model of AD, the 3xTG, which is known to present astrocyte atrophy at the same early age in which the NGF treatment was performed (Yeh et al., 2011), could rescue astrocyte morphology (Supplementary Figure S6).